HeiLongJiang ZBD Pharmaceutical Hits Day Low Amid Price Pressure at CNY 5.39

HeiLongJiang ZBD Pharmaceutical Co., Ltd. experienced a significant decline in its stock performance today, with shares dropping by 7.43%. The stock reached an intraday low of CNY 5.39, reflecting ongoing challenges within the company. Over the past week, the stock has seen a steep decline of 17.84%, and its performance over the last month has been even more pronounced, with a decrease of 24.73%. In the context of longer-term performance, HeiLongJiang ZBD has faced substantial setbacks, with a year-to-date decline of 38.63% and a staggering 52.18% drop over the past year. The company's market capitalization stands at CNY 6,226 million, categorizing it as a mid-cap entity in the pharmaceuticals and biotechnology sector. Financial metrics indicate a low return on capital employed (ROCE) of 2.85% and a return on equity (ROE) of -26.62%, suggesting challenges in profitability. Additionally, the company has reported negative results for the last three consecutive quarters, contributing to its current market position.